QCM Cayman’s Merck MRK Stock Holding History

QCM Cayman’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-11,423	Closed	-$693K	–	319
2017 Q1	$693K	Buy	+11,423	New	+$693K	0.13%	167

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

QCM Cayman's MRK Position: Q4 2019 in Review

QCM Cayman sold out of Merck (MRK) in Q4 2019, closing a stake of 4,348 shares — an estimated $349K sold.

QCM Cayman first reported a position in MRK in Q2 2016 and held it in 3 quarters. The position peaked at $504K in Q4 2017. 2,537 funds tracked by Wall St. Rank hold MRK as of Q4 2019.

QCM Cayman reported no remaining Merck position as of Q4 2019 after selling out during the quarter.
QCM Cayman sold 4,348 Merck shares in Q4 2019, an estimated $349K.
QCM Cayman first reported a position in Merck in Q2 2016 and held it in 3 quarters.
QCM Cayman's Merck position peaked at $504K in Q4 2017.
2,537 funds tracked by Wall St. Rank held Merck as of Q4 2019.

Based on QCM Cayman's 13F filing for Q4 2019, filed 14 Feb 2020.